Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2014 | 09-2013 | 09-2012 | 09-2011 | 09-2010 | |
| Sales | 57,439 | 56,132 | 51,928 | 52,756 | 54,488 |
| Cost of Goods | 8,016 | 7,898 | 7,418 | 6,750 | 6,806 |
| Gross Profit | 49,423 | 48,234 | 44,510 | 46,006 | 47,682 |
| Operating Expenses | 30,863 | 30,312 | 28,586 | 31,233 | 36,497 |
| Operating Income | 18,576 | 18,820 | 16,342 | 15,523 | 11,991 |
| Other Income | -104 | 1,540 | -36 | 1,006 | -6,607 |
| Pre-tax Income | 18,472 | 20,360 | 16,306 | 16,529 | 5,384 |
| Income Tax | 6,265 | 5,781 | 6,177 | 5,604 | 4,979 |
| Net Income Continuous | 12,207 | 14,579 | 10,129 | 10,925 | 405 |
| Net Income Discontinuous | -176 | 588 | 102 | -29,431 | -21,494 |
| Net Income | $12,031 | $15,167 | $10,231 | $-18,506 | $-21,089 |
| EPS Basic Total Ops | 0.88 | 1.05 | 0.59 | -1.06 | -1.21 |
| EPS Basic Continuous Ops | 0.90 | 1.01 | 0.58 | 0.63 | 0.02 |
| EPS Basic Discontinuous Ops | -0.01 | 0.04 | 0.01 | -1.69 | -1.24 |
| EPS Diluted Total Ops | 0.87 | 1.03 | 0.59 | -1.06 | -1.21 |
| EPS Diluted Continuous Ops | 0.88 | 0.99 | 0.58 | 0.63 | 0.02 |
| EPS Diluted Discontinuous Ops | -0.01 | 0.04 | 0.01 | -1.69 | -1.24 |
| EBITDA(a) | $21,291 | $21,706 | $19,302 | $18,775 | $15,739 |